Industry News
Pharmaceutical Industry News
F.D.A. Approves New Nasal Spray for Migraines
Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.
People With ADHD Claim Adderall Is ‘Different’ Amid Ongoing Shortage
Since the nationwide shortage started, some have said their medication no longer helps with their symptoms. But there could be other factors at play.
Executive Sentenced for Scheming to Flood Northeast With Opioids
Laurence F. Doud III, who headed the Rochester Drug Cooperative, will serve more than two years for conspiring to funnel “staggering” amounts of narcotics to pill mills.
Kidnapping in Mexico Draws Attention to Medical Tourism
Here’s what experts say about the risks and promises of traveling abroad for cost-efficient care.
Walgreens Faces Blowback for Not Offering Abortion Pill in 21 States
The chain’s situation shows the complicated legal and reputational landscape that it and its competitors must navigate in the post-Roe era.
Preterm Birth Drug Withdrawn After 12 Years
The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.
Joe Biden: My Plan to Extend Medicare for Another Generation
Medicare is the rock-solid guarantee that Americans count on. My budget will make the Medicare trust fund solvent beyond 2050.
Could the Next Blockbuster Drug Be Lab-Rat Free?
Alternatives to animal testing are gaining momentum.
The ‘Wild West’ of Ketamine Treatment
Readers discuss the use of ketamine to treat depression. Also: Black maternal mortality; abortion; housing in the suburbs; a baseball fan’s complaint.
A Statin Alternative Joins Drugs That Can Reduce Heart Attack Risk
Bempedoic acid lowers cholesterol, and a study found a modest effect on cardiac illness. But whether patients are any more willing to take it remains to be seen, experts said.
Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative States
The decision applies to 21 states whose attorneys general threatened Walgreens and other pharmacies with legal action if they dispensed the pill there.
More Doctors Can Now Prescribe Buprenorphine to Opioid Users. Will It Help?
The federal government loosened regulations for buprenorphine, but health experts warn that entrenched problems around training and access could stall efforts to get people the medication.
New Approaches to the Drug Overdose Crisis
Responses to Jeneen Interlandi’s article and the accompanying editorial. Also: Europe and Ukraine; private prayer; Fox News and Dominion Voting Systems.
Eli Lilly to Cut Insulin Price and Cap Monthly Out of Pocket Costs at $35
The company also trumpeted an existing policy that caps monthly out-of-pocket cost for its lifesaving products at $35.
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addiction
The case illustrates the enormous challenges that victims of the opioid crisis have had in getting compensation from the pharmaceutical industry, despite its pledge of billions of dollars to state and local governments.
FDA Panel Recommends 2 RSV Vaccines for Older Adults
The shots, if approved by the agency, would be the first vaccines publicly available against a respiratory virus that kills thousands a year. Some advisers did cite a small but identifiable health risk.
Why Are Ketamine Ads Following Me Around the Internet?
The rules around pharmaceutical advertising need a 21st-century update.
¿Qué pasa cuando dejas de tomar Ozempic?
Cada vez más pacientes recurren a los medicamentos para la diabetes que también son prescritos para bajar de peso y se ha generado una escasez. Los médicos afirman que dejar estos fármacos puede tener efectos
A Drug Company Exploited a Safety Requirement to Make Money
With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition.
Biden Proposal Would Ban Online Prescribing of Certain Drugs
Some medications, like Ritalin and Vicodin, would require an in-person doctor’s visit under the new rules, a reaction to the pandemic-era rise of telemedicine.